A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 67
- Population
- ALL · 65 Years
- Duration
- 2019-02-21 to 2022-05-10
- Intervention
- Geriatric intervention
- Comparator
- control.
- Outcomes measured
- 30-second chair stand test (30s-CST) — baseline to 14 weeks after surgery; physical function and capacity - 6-minute-walk-test — baseline to 14 weeks after surgery; physical function and capacity - hand grip strength — baseline to 14 weeks after surgery; physical function and capacity - 6-meter gait speed — baseline to 14 weeks after surgery; Patient reported Quality of Life: EORTC — baseline to 14 weeks after surgery; Patient reported Quality of Life: EORTC ELD14 — baseline to 14 weeks after surgery; Quality of recovery after surgery: questionnaire — 1 day before surgery (baseline) to 3 days after surgery; body composition — baseline to 14 weeks after surgery.; inflammatory biomarker - CRP — baseline to 14 weeks after surgery; inflammatory biomarker - Interleukin 6 — baseline to 14 weeks after surgery; inflammatory biomarker YKL-40 — baseline to 14 weeks after surgery; inflammatory biomarkers immuno-oncology — baseline to 14 weeks after surgery; sarcopenia biomarker GDF-11 — baseline to 14 weeks after surgery; sarcopenia biomarker GDF — baseline to 14 weeks after surgery; Postoperative complications — 30 days + 90 days; readmission — 30 days after surgery and 90 days after surgery; survival — 10 years; mortality — baseline to 3 months; number of patients to start up of adjuvant chemotherapy after surgery. — 14 weeks; start up time of adjuvant chemotherapy after surgery — 14 weeks
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.